BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miravitlles M, Nuñez A, Torres-durán M, Casas-maldonado F, Rodríguez-hermosa JL, López-campos JL, Calle M, Rodríguez E, Esquinas C, Barrecheguren M. The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 2020;17:346-54. [DOI: 10.1080/15412555.2020.1795824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Miravitlles M, Calle M, Molina J, Almagro P, Gómez J, Trigueros JA, Cosío BG, Casanova C, López-campos JL, Riesco JA, Simonet P, Rigau D, Soriano JB, Ancochea J, Soler-cataluña JJ. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD. Archivos de Bronconeumología 2022;58:T69-81. [DOI: 10.1016/j.arbres.2021.03.026] [Reference Citation Analysis]
2 Martinez-González C, Blanco I, Diego I, Bueno P, Miravitlles M. Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide. Int J Chron Obstruct Pulmon Dis 2021;16:2617-30. [PMID: 34556982 DOI: 10.2147/COPD.S327803] [Reference Citation Analysis]
3 Miravitlles M, Calle M, Molina J, Almagro P, Gómez J, Trigueros JA, Cosío BG, Casanova C, López-campos JL, Riesco JA, Simonet P, Rigau D, Soriano JB, Ancochea J, Soler-cataluña JJ. Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD. Archivos de Bronconeumología (English Edition) 2021. [DOI: 10.1016/j.arbr.2021.03.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
4 Miravitlles M, Calle M, Molina J, Almagro P, Gómez JT, Trigueros JA, Cosío BG, Casanova C, López-Campos JL, Riesco JA, Simonet P, Rigau D, Soriano JB, Ancochea J, Soler-Cataluña JJ. Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD. Arch Bronconeumol (Engl Ed) 2021:S0300-2896(21)00103-4. [PMID: 33840553 DOI: 10.1016/j.arbres.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Domínguez-González C, Madruga-Garrido M, Hirano M, Martí I, Martín MA, Munell F, Nascimento A, Olivé M, Quan J, Sardina MD, Martí R, Paradas C. Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency. Orphanet J Rare Dis 2021;16:407. [PMID: 34600563 DOI: 10.1186/s13023-021-02030-w] [Reference Citation Analysis]
6 Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, Ferreira F, Clarenbach C, Torres-Duran ML, Turner AM, Miravitlles M. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. Int J Chron Obstruct Pulmon Dis 2022;17:53-64. [PMID: 35023913 DOI: 10.2147/COPD.S346051] [Reference Citation Analysis]